Efficacy and Safety of Electroconvulsive Therapy in Adolescents: A Retrospective Chart Review Study From Turkey.
Journal
The journal of ECT
ISSN: 1533-4112
Titre abrégé: J ECT
Pays: United States
ID NLM: 9808943
Informations de publication
Date de publication:
Mar 2020
Mar 2020
Historique:
pubmed:
17
5
2019
medline:
18
5
2021
entrez:
17
5
2019
Statut:
ppublish
Résumé
The aim of this study was to report the efficacy and safety of electroconvulsive therapy (ECT) in manic, depressed, psychotic, and catatonic adolescent patients. Medical records of 78 adolescents who had received ECT in Department of Psychiatry, Gaziantep University Medical Faculty, during 2011 to 2017 were reviewed. Sixty-two subjects in this sample were identified to have complete records and met the study inclusion criteria. The mean ± SD age of subjects was 17.11 ± 1.04 years and female sex was 53.2% (n = 33). Primary the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision or the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition diagnoses were bipolar mood disorders (n = 33, 53.2%), major depressive disorder (n = 16, 25.8%), schizophrenia (n = 8, 12.9%), and schizoaffective disorders (n = 5, 8.1%). Electroconvulsive therapy was significantly effective in treating manic, depressive, psychotic, and catatonia symptoms as evidenced by significant differences in pretreatment and posttreatment scores in outcome measures including Hamilton Depression Rating Scale, Young Mania Rating Scale, Positive and Negative Syndrome Scale, and Clinical Global Impression-Severity Scale (P < 0.001). Presence of comorbidity adversely affected treatment response (P = 0.001). However, ECT was also effective in those with comorbid diagnoses (P < 0.001). Depressive symptoms in patients with bipolar depression responded better than those with unipolar depression (P = 0.012). Electroconvulsive therapy was generally safe with subjective memory complaints (85%), headache (69%), and prolonged seizure (8%) as the reported adverse effects possibly related to ECT. Four subjects (6%) developed a manic switch during ECT. Electroconvulsive therapy is an effective and a safe treatment option in adolescent patients with severe and resistant psychopathology. Although comorbidity may decrease treatment response, ECT seems to be effective even in the presence of multiple psychiatric diagnoses.
Identifiants
pubmed: 31094872
doi: 10.1097/YCT.0000000000000602
pii: 00124509-202003000-00011
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
54-59Références
Kelly KG, Zisselman M. Update on electroconvulsive therapy (ECT) in older adults. J Am Geriatr Soc. 2000;48:560–566.
Weiner RD, Reti IM. Key updates in the clinical application of electroconvulsive therapy. Int Rev Psychiatry. 2017;29:54–62.
Kaliora SC, Braga RJ, Petrides G, et al. The practice of electroconvulsive therapy in Greece. J ECT. 2013;29:219–224.
Loiseau A, Harrisson MC, Beaudry V, et al. Electroconvulsive therapy use in youth in the Province of Quebec. J Can Acad Child Adolesc Psychiatry. 2017;26:4–11.
Zhang QE, Wang ZM, Sha S, et al. Common use of electroconvulsive therapy for chinese adolescent psychiatric patients. J ECT. 2016;32:251–255.
Rey JM, Walter G. Half a century of ECT use in young people. Am J Psychiatry. 1997;154:595–602.
De Meulenaere M, De Meulenaere J, Ghaziuddin N, et al. Experience, knowledge, and attitudes of child and adolescent psychiatrists in Belgium toward pediatric electroconvulsive therapy. J ECT. 2018;34:247–252.
Cohen D, Flament M, Taieb O, et al. Electroconvulsive therapy in adolescence. Eur Child Adolesc Psychiatry. 2000;9:1–6.
Walter G, Koster K, Rey JM. Electroconvulsive therapy in adolescents: experience, knowledge, and attitudes of recipients. J Am Acad Child Adolesc Psychiatry. 1999;38:594–599.
Bertagnoli MW, Borchardt CM. A review of ECT for children and adolescents. J Am Acad Child Adolesc Psychiatry. 1990;29:302–307.
Shoirah H, Hamoda HM. Electroconvulsive therapy in children and adolescents. Expert Rev Neurother. 2011;11:127–137.
Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56.
Akdemir A, Türkçapar MH, Örsel SD, et al. Reliability and validity of the Turkish version of the Hamilton Depression Rating Scale. Compr Psychiatry. 2001;42:161–165.
Young RC, Biggs JT, Ziegler VE, et al. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry. 1978;133:429–435.
Karadağ F, Oral T, Yalçin FA, et al. Reliability and validity of Turkish translation of Young Mania Rating Scale. Turk Psikiyatri Derg. 2001;13:107–114.
Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13:261–276.
Kostakoglu E, Batur S, Tiryaki A, et al. Reliability and validity of the Turkish version of the Positive and Negative Syndrome Scale (PANSS). Turk J Psychol. 1999;14:23–34.
Guy W. ECDEU Assessment Manual for Psychopharmacology. US Department of Health, and Welfare, No (ADM) 76–338. Rockville, MD: National Institute of Mental Health; 1976:534–537.
Turkish Ministry of Health. Elektrokonvülsif Tedavi Uygulama Yönergesi. 2006; Available at: https://saglik.gov.tr/TR,11235/elektro-konvulsif-tedavi-uygulama-yonergesi.html. Accessed July 28, 2018.
Akca A, Ak M, Sutcugil L, et al. Comparison of sertraline and venlafaxine treatments for depression in Parkinson's disease. Noro Psikiyatr Ars. 2011;48:201–206.
Welten CC, Koeter MW, Wohlfarth T, et al. Placebo response in antipsychotic trials of patients with acute mania: results of an individual patient data meta-analysis. Eur Neuropsychopharmacol. 2015;25:1018–1026.
Moise FN, Petrides G. Case study: electroconvulsive therapy in adolescents. J Am Acad Child Adolesc Psychiatry. 1996;35:312–318.
Kahn RS, Schulz SC, Palazov VD, et al. Efficacy and tolerability of once-daily extended release quetiapine fumarate in acute schizophrenia: a randomized, double-blind, placebo-controlled study. J Clin Psychiatry. 2007;68:832–842.
Kolmogorov A. Sulla determinazione empirica di una lgge di distribuzione. Inst Ital Attuari, Giorn. 1933;4:83–91.
Ghaziuddin N, Kutcher SP, Knapp P. Practice parameter for use of electroconvulsive therapy with adolescents. J Am Acad Child Adolesc Psychiatry. 2004;43:1521–1539.
Grover S, Malhotra S, Varma S, et al. Electroconvulsive therapy in adolescents: a retrospective study from north India. J ECT. 2013;29:122–126.
Consoli A, Benmiloud M, Wachtel L, et al. Electroconvulsive therapy in adolescents with the catatonia syndrome: efficacy and ethics. J ECT. 2010;26:259–265.
Egeland JA, Hostetter AM, Pauls DL, et al. Prodromal symptoms before onset of manic-depressive disorder suggested by first hospital admission histories. J Am Acad Child Adolesc Psychiatry. 2000;39:1245–1252.
Sienaert A, Vansteelandt P, Demyttenaere K, et al. Ultra-brief pulse ECT in bipolar and unipolar depressive disorder: differences in speed of response. Bipolar Disord. 2009;11:418–424.
Dierckx B, Heijnen WT, van den Broek WW, et al. Efficacy of electroconvulsive therapy in bipolar versus unipolar major depression: a meta-analysis. Bipolar Disord. 2012;14:146–150.
Haq AU, Sitzmann AF, Goldman ML, et al. Response of depression to electroconvulsive therapy: a meta-analysis of clinical predictors. J Clin Psychiatry. 2015;76:1374–1384.
Ghaziuddin N, Dumas S, Hodges E. Use of continuation or maintenance electroconvulsive therapy in adolescents with severe treatment-resistant depression. J ECT. 2011;27:168–174.
Haq AU, Ghaziuddin N. Maintenance electroconvulsive therapy for aggression and self-injurious behavior in two adolescents with autism and catatonia. J Neuropsychiatry Clin Neurosci. 2014;26:64–72.
Andrade C, Kurinji S. Continuation and maintenance ECT: a review of recent research. J ECT. 2002;18:149–158.
Wachtel LE. Treatment of catatonia in autism spectrum disorders. Acta Psychiatr Scand. 2019;139:46–55.
Consoli A, Cohen J, Bodeau N, et al. Electroconvulsive therapy in adolescents with intellectual disability and severe self-injurious behavior and aggression: a retrospective study. Eur Child Adolesc Psychiatry. 2013;22:55–62.
Wachtel LE, Hermida A, Dhossche DM. Maintenance electroconvulsive therapy in autistic catatonia: a case series review. Prog Neuropsychopharmacol Biol Psychiatry. 2010;34:581–587.
Sengul MC, Kenar AN, Hanci E, et al. Practice of acute and maintenance electroconvulsive therapy in the psychiatric clinic of a university hospital from Turkey: between 2007 and 2013. Clin Psychopharmacol Neurosci. 2016;14:57.
Shiozawa P, Trevizol A, Bernardon RR, et al. Electroconvulsive therapy for a psychotic adolescent during the first trimester of pregnancy: case study. Trends Psychiatry Psychother. 2015;37:166–167.
Serim B, Ulas H, Ozerdem A, et al. Electroconvulsive therapy in an adolescent pregnant patient. Prog Neuropsychopharmacol Biol Psychiatry. 2010;34:546–547.
Leiknes KA, Cooke MJ, Jarosch-von Schweder L, et al. Electroconvulsive therapy during pregnancy: a systematic review of case studies. Arch Womens Ment Health. 2015;18:1–39.
Pacifici GM, Nottoli R. Placental transfer of drugs administered to the mother. Clin Pharmacokinet. 1995;28:235–269.
De Asis SJ, Helgeson L, Ostroff R. The use of propofol to prevent fetal deceleration during electroconvulsive therapy treatment. J ECT. 2013;29:e57–e58.
Zhand N, Courtney DB, Flament MF. Use of electroconvulsive therapy in adolescents with treatment-resistant depressive disorders: a case series. J ECT. 2015;31:238–245.
Stein D, Kurtsman L, Stier S, et al. Electroconvulsive therapy in adolescent and adult psychiatric inpatients—a retrospective chart design. J Affect Disord. 2004;82:335–342.
Sackeim HA, Prudic J, Nobler MS, et al. Effects of pulse width and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. Brain Stimul. 2008;1:71–83.
Ghaziuddin N, King CA, Naylor MW, et al. Electroconvulsive treatment in adolescents with pharmacotherapy-refractory depression. J Child Adolesc Psychopharmacol. 1996;6:259–271.
Whittaker R, Scott A, Gardner M. The prevalence of prolonged cerebral seizures at the first treatment in a course of electroconvulsive therapy. J ECT. 2007;23:11–13.
Grover S, Hazari N, Kate N. Combined use of clozapine and ECT: a review. Acta Neuropsychiatr. 2015;27:131–142.
Puffer CC, Wall CA, Huxsahl JE, et al. A 20 year practice review of electroconvulsive therapy for adolescents. J Child Adolesc Psychopharmacol. 2016;26:632–636.